MLTX

Healthcare Biotechnology

MoonLake Immunotherapeutics

$11.41

-0.21 -1.81% today

Price History

Not enough data

Key Stats

Market Cap

971.07M

Avg Volume

1.39M

EPS

-$3.83

52W High

$23.29

52W Low

$8.18

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-3.43

P/B Ratio

2.23

EV/EBITDA

-2.02

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Equity

(67.5%)

Return on Assets

(32.4%)

Liquidity & Leverage

Current Ratio

12.56

Quick Ratio

11.97

Debt / Equity

0.24

Total Cash

537.03M

Total Debt

101.53M

About

MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases in dermatology and rheumatology, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.